Our Media centre contains a range of resources including our latest and archived press releases and news updates, conferences and events we attend, our image and video library and social media information.

These press releases and news updates are intended for media and investors only


See all Conferences and Events

22-26 July 2024

25th international AIDS conference in Munich will host up to 15,000 people to discuss the latest advancements in HIV research.

4-9 December 2023

The ICASA conference provides a strong platform for leaders, scientists, activists and community in Africa to come together to advance the HIV response. ViiV Healthcare is proud to be at this event: learn more about our presence at ICASA 2023.

18 - 21 OCTOBER 2023

The European AIDS Clinical Society Conference (EACS) is an opportunity for the HIV community to come together to discuss the latest in HIV research and how, together, we can continue to support the HIV community.

Person living with HIV in Uruguay holding his cat

Images and video gallery

Access our gallery of images and videos.

View here

Media contacts

Media contact details for our global headquarters and USA. For press contacts in our local operating companies please visit our country websites.

In you have a media query please use our Contact our team form here.

Global Press Office

Rachel Jaikaran
Head of Global Communications ViiV Healthcare
Tel: +44 7823 523 755

US Press Office

Audrey Abernathy
Head of ViiV US External Affairs & Communications
Tel: +1 919 605 4521

NP-GBL-HVX-COCO-220039 | May 2024

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at or search for MHRA Yellowcard in the Google Play or Apple App store. By reporting side effects, you can help provide more information on the safety of this medicine.

If you are from outside the UK, you can report adverse events to GSK/ViiV by selecting your region and market, here.